Table 4.
Univariate and multivariate analyses of independent prognostic factors for renal survival (ESRD)
| Risk Factor | Univariable | Multivariable | ||
|---|---|---|---|---|
| HR (95% CI) | P Value | HR (95% CI) | P Value | |
| TA-H | 4.21 (1.66 to 10.64) | 0.02 | 2.84 (1.06 to 7.3) | 0.04 |
| TA-P | 4.88 (1.88 to 12.65) | 0.01 | 2.82 (1.04 to 7.66) | 0.04 |
| Age at baseline | 1.02 (1.01 to 1.05) | 0.05 | 0.97 (0.94 to 0.99) | 0.05 |
| Renal function at baseline | 0.96 (0.94 to 0.98) | <0.001 | 0.97 (0.95 to 0.99) | 0.03 |
| IS treatments | 1.66 (0.67 to 4.09) | 0.26 | ||
| SBP | 1.01 (1.01 to 1.02) | 0.02 | ||
| DBP | 1.01 (1 to 1.03) | 0.03 | ||
| M1 | 2.67 (1.11 to 6.45) | 0.03 | ||
| E1 | 2.16 (0.62 to 7.43) | 0.22 | ||
| S1 | 2.45 (0.98 to 6.09) | 0.06 | ||
| T1–T2 | 5.55 (2.29 to 13.33) | 0.03 | 3.19 (1.72 to 8.87) | 0.001 |
HR, hazard ratio; 95% CI, 95% confidence interval; TA-H, time-averaged hematuria; TA-P, time-averaged proteinuria; IS, immunosuppressive; SBP, systolic BP; DBP, diastolic BP; M1, present mesangial hypercellularity; E1, present endocapillary hypercellularity; S1, present segmental glomerulosclerosis; T1–T2, tubular atrophy/interstitial fibrosis >25%.